Chemicals & Advanced Materials Global On demand · 24-48h

Global Artemisinin Market Strategic Research Report

Global Artemisinin Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Artemisinin Market
$1082025
19.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Extraction From Artemisia Annua, Semisynthetic Artemisinin

By Application: Antimalarial Injections, Antimalarial Tablets

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Fosun Group, Natural Bio-engineering, BIONEXX, CAT KHANH, BEEPZ, Huafang Ketai, Huali Phamra

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 111 pages
Market size 2025
$108
Million USD
Forecast CAGR
19.5%
2025-2032
Forecast 2032
$375.8
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Artemisinin market size is predicted to grow from US$ 108 million in 2025 to US$ 372 million in 2032; it is expected to grow at a CAGR of 19.5% from 2026 to 2032.

Artemisinin is a natural compound extracted from the sweet wormwood plant (Artemisia annua), widely recognized for its potent antimalarial properties. It is effective in rapidly reducing malaria parasite levels in the blood and is a primary component of artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria worldwide. Due to its effectiveness and rapid action, artemisinin has been a critical advancement in global malaria control efforts.

The artemisinin market is driven primarily by the global need to combat malaria, a disease that affects millions, especially in tropical and subtropical regions. As a key ingredient in artemisinin-based combination therapies (ACTs), the standard treatment for malaria, demand for artemisinin remains strong, especially in regions with high malaria prevalence. Increasing global health initiatives and funding from governments and organizations like the World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria continue to support artemisinin production and distribution. Additionally, advancements in synthetic biology and semi-synthetic production methods are helping to stabilize supply.

The artemisinin market faces challenges such as dependency on seasonal agricultural production from Artemisia annua, which can lead to fluctuations in supply and pricing. Climate variability and agricultural risks can impact the availability and quality of raw material, causing potential shortages. Additionally, resistance to artemisinin is emerging in some regions, particularly in Southeast Asia, raising concerns over the long-term efficacy of artemisinin-based therapies. This resistance is pushing researchers and health organizations to seek alternative treatments, which may impact future demand for artemisinin.

This report presents a comprehensive overview of the global Artemisinin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Extraction From Artemisia Annua
  • Semisynthetic Artemisinin

Segment by Application

  • Antimalarial Injections
  • Antimalarial Tablets

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Artemisinin market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Antimalarial Injections, Antimalarial Tablets evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Artemisinin Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 19.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$108
2025
Forecast
$375.8
2032
CAGR
19.5%
2025–2032
영역들
5
global
Key companies
SanofiKPC PharmaceuticalsKerui nanhaiGuangxi xiancaotangFosun GroupNatural Bio-engineeringBIONEXXCAT KHANH
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Extraction From Artemisia AnnuaSemisynthetic Artemisinin
By Application
Antimalarial InjectionsAntimalarial Tablets

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Extraction From Artemisia Annua
  • 3.1.3 Semisynthetic Artemisinin
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Antimalarial Injections
  • 4.1.3 Antimalarial Tablets
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Sanofi
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 KPC Pharmaceuticals
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Kerui nanhai
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Guangxi xiancaotang
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Fosun Group
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Natural Bio-engineering
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BIONEXX
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CAT KHANH
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 BEEPZ
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Huafang Ketai
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Huali Phamra
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Artemisinin market?
The global Artemisinin market is estimated at US$ 108 million in 2025 (base year) and is projected to reach US$ 372 million by 2032.
What is the forecast CAGR for the Artemisinin market?
The market is expected to grow at a CAGR of 19.5% from 2026 to 2032, expanding from US$ 108 million in 2025 to US$ 372 million in 2032, roughly 3.4 times its base-year value.
What is Artemisinin?
Artemisinin is a natural compound extracted from the sweet wormwood plant (Artemisia annua), widely recognized for its potent antimalarial properties. It is effective in rapidly reducing malaria parasite levels in the blood and is a primary component of artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria worldwide. Due to its effectiveness and rapid action, artemisinin has been a critical advancement in global malaria control efforts.
What are the main segments of the Artemisinin market by type?
By type, the market is segmented into Extraction From Artemisia Annua and Semisynthetic Artemisinin.
Which applications drive demand in the Artemisinin market?
Key applications covered include Antimalarial Injections and Antimalarial Tablets.
Who are the key players in the Artemisinin market?
Key players profiled include Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Fosun Group, Natural Bio-engineering, BIONEXX and CAT KHANH, among 11 companies covered in total.
Which regions and countries are covered for Artemisinin?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Artemisinin market?
The artemisinin market is driven primarily by the global need to combat malaria, a disease that affects millions, especially in tropical and subtropical regions.
What challenges does the Artemisinin market face?
The artemisinin market faces challenges such as dependency on seasonal agricultural production from Artemisia annua, which can lead to fluctuations in supply and pricing.
Who should buy the Artemisinin market report?
The report is intended for manufacturers and solution providers, distributors and end users in Antimalarial Injections and Antimalarial Tablets, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Artemisinin market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.